statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Heron Therapeutics Announces the Inclusion of ZYNRELEF as a Qualifying Product Under the Proposed 2025 Non-Opioid Policy for Pain Relief Under the OPPS and the ASC Payment System

Heron Therapeutics Announces the Inclusion of ZYNRELEF as a Qualifying Product Under the Proposed 2025 Non-Opioid Policy for Pain Relief Under the OPPS and the ASC Payment System Heron Therapeutics...

Heron Therapeutics Announces Acceptance of the Prior Approval Supplement Application for ZYNRELEF Vial Access Needle ("VAN")

Heron Therapeutics Announces Acceptance of the Prior Approval Supplement Application for ZYNRELEF Vial Access Needle ('VAN') Heron Therapeutics Announces Acceptance of the Prior Approval Supplement...

Heron Therapeutics Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF Vial Access Needle ("VAN")

Heron Therapeutics Announces Prior Approval Supplement Submission to the FDA for ZYNRELEF Vial Access Needle ('VAN') Heron Therapeutics Announces Prior Approval Supplement Submission to the FDA for...

Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates

Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent Corporate Updates Heron Therapeutics Announces First Quarter 2024 Financial Results and Highlights Recent...

Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City

Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City PR Newswire SAN DIEGO, April 11, 2024 SAN DIEGO...

Congress Park Capital LLC Purchases 1,209,500 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX)

Congress Park Capital LLC increased its position in shares of Heron Therapeutics, Inc. (NASDAQ:HRTX - Free Report) by 205.3% during the fourth quarter, according to its most recent filing with the...

Heron Therapeutics (NASDAQ:HRTX) Shares Cross Above 200 Day Moving Average of $1.73

Heron Therapeutics, Inc. (NASDAQ:HRTX - Get Free Report)'s stock price passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $1.73 and traded...

Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference

Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference...

Heron Therapeutics Announces New Principal Accounting Officer

Heron Therapeutics (HRTX) has issued an update. Ira Duarte has been appointed as the new principal accounting officer of Heron Therapeutics, Inc...

Needham & Company LLC Increases Heron Therapeutics (NASDAQ:HRTX) Price Target to $5.00

Heron Therapeutics (NASDAQ:HRTX  Get Free Report) had its target price raised by equities research analysts at Needham & Company LLC from $4.00 to $5.00 in a report issued on Wednesday...

Heron Therapeutics, Inc is a biotechnology company, which engages in the development of pharmaceutical products for acute care and oncology patients. Its product portfolio includes SUSTOL, CINVANTI, HTX-011 and HTX-034. The company was founded in February 1983 and is headquartered in San Diego, CA.

Volume	1.7M
52-Wk High	$3.93
52-Wk Low	$0.50

HRTX Heron Therapeutics Inc

About

Feed

News

Sentiment

Earnings

Fundamentals